PainReform Ltd. Made Headway
Mon, Mar 21, 2022 at 05:30 PM
PainReform Ltd. (PRFX:NASDAQ) shot up at $1.55, a gain of 39.6%. The stock appeared on our News Catalysts scanner on Mon, Mar 21, 2022 at 10:05 AM in the 'MISCELLANEOUS' category. From Fri, Mar 04, 2022, the stock recorded 40.00% Up Days and 36.36% Green Days
About PainReform Ltd. (PRFX:NASDAQ)
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics.
Top 10 Gainers:
- NeuroSense Therapeutics Ltd. (NRSN:NASDAQ), 299.36%
- Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ), 58.44%
- Yumanity Therapeutics Inc. (YMTX:NASDAQ), 58.04%
- BitNile Holdings Inc. (NILE:NYSEMKT), 48.56%
- UTime Limited (UTME:NASDAQ), 44.79%
- Dermata Therapeutics Inc. (DRMA:NASDAQ), 44%
- CYREN Ltd. (CYRN:NASDAQ), 43.22%
- PainReform Ltd. (PRFX:NASDAQ), 39.64%
- Corbus Pharmaceuticals Holdings, Inc. (CRBP:NASDAQ), 38.02%
- O2Micro International Limited (OIIM:NASDAQ), 34.37%